Abstract
Application of Bayesian methods is one the tools that can be used to face the multiple challenges that are met when clinical trials must be conducted in rare diseases. We propose in this work to use a dynamic Bayesian borrowing approach, based on a mixture prior, to complement the control arm of a comparative trial and estimate the mixture parameter by an Empirical Bayes approach. The method is compared, using simulations, with an approach based on a pre-specified (non-adaptive) informative prior. The simulation study shows that the proposed method exhibits similar power as the non-adaptive prior and drastically reduce type I error in case of severe discrepancy between the informative prior and the study control arm data. In case of limited discrepancy between the informative prior and the study control arm data, then our proposed adaptive prior does not reduce the inflation of the type I error.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Liu J, Barrett JS, Leonardi ET, Lee L, Roychoudhury S, Chen Y, Panayiota Trifillis P (2022) Natural history and Real-World Data in Rare Diseases: applications, Limitations, and future perspectives. J Clin Pharmacol 62(S2):38–S5. https://doi.org/10.1002/jcph.2134
Chen M-H, Ibrahim J (2000) Power prior distributions for regression models. Stat Sci 15(1):46–60. https://doi.org/10.1214/ss/1009212673
Gajewski BJ, Reese CS, Colombo J, Carlson SE (2016) Commensurate Priors on a Finite Mixture Model for Incorporating Repository Data in Clinical Trials. Statistics in Biopharmaceutical Research Volume 8, 151–160. https://doi.org/10.1080/19466315.2015.1133453 Psioda M and Xueb X, 2020. A Bayesian Adaptive Two-Stage Design for Pediatric Clinical Trials. Journal of Biopharmaceutical Statistics 30 (6), 1091–1108 https://doi.org/10.1080/10543406.2020.1821704
Depaoli S, Yang Y, Felt J (2017) Using bayesian statistics to model uncertainty in mixture models: a sensitivity analysis of Priors. Struct Equ Model Volume 24(Issue 2):198–215. https://doi.org/10.1080/10705511.2016.1250640
Wakefield J, De Vocht F, Hung RJ (2010) Bayesian mixture modeling of gene-environment and gene-gene interactions. Genet Epidemiol 34:16–25. https://doi.org/10.1002/gepi.20429
Lin J, Gamalo-Siebers M, Tiwari R (2021) Ensuring exchangeability in data-based priors for a bayesian analysis of clinical trials. Pharm Stat 21(2):1–18. https://doi.org/10.1002/pst.2172
Gelman A, Carlin JB, Stern HS, Dunson DB, Vehtari A, Rubin DB (2013) Bayesian data analysis. Chapman & Hall/CRC, Boca Raton, FL
Author information
Authors and Affiliations
Contributions
The author wrote the manusript and made the computations related to it.
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sebastien, B. Empirical bayes approach for dynamic bayesian borrowing for clinical trials in rare diseases. J Pharmacokinet Pharmacodyn 50, 495–499 (2023). https://doi.org/10.1007/s10928-023-09860-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10928-023-09860-0